| Related Articles |
Management of acute hypercapnic respiratory failure.
Curr Opin Crit Care. 2015 Nov 30;
Authors: Pisani L, Corcione N, Nava S
Abstract
PURPOSE OF REVIEW: The objective of this article is to review the most recent literature regarding the management of acute hypercapnic respiratory failure (AHRF).
RECENT FINDINGS: In the field of AHRF management, noninvasive ventilation (NIV) has become the standard method of providing primary mechanical ventilator support. Recently, extracorporeal carbon dioxide removal (ECCO2R) devices have been proposed as new therapeutic option.
SUMMARY: NIV is an effective strategy in specific settings and in selected population with AHRF. To date, evidence on ECCO2R is based only on case reports and case-control trials. Although the preliminary results using ECCO2R to decrease the rate of NIV failure and to wean hypercapnic patients from invasive ventilation are remarkable; further randomized studies are needed to assess the effects of this technique on both short-term and long-term clinical outcomes.
PMID: 26627537 [PubMed - as supplied by publisher]